EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Association of STAT3, CYP3A5 , and ABCG2 Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients

Masaaki Tanda, Kazuhiro Yamamoto, Tomoki Hori, Hiroki Nishiguchi, Miki Yagi, Michiko Shimizu, Toru Konishi, Tomonori Ozaki, Natsue Yoshioka, Motoko Tachihara, Takefumi Ito, Shigeki Ikushima und 2 weitere

Anticancer Research · 2023

DOI: 10.21873/anticanres.16331 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Anticancer Research, 2023. Verfasst von Masaaki Tanda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kobe University Hospital, Kobe, Japan. Hauptthemen laut MEDLINE: Aniline Compounds, Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aniline CompoundsAntineoplastic AgentsCarcinoma, Non-Small-Cell LungLung NeoplasmsParonychiaProtein Kinase InhibitorsFemaleHumansCytochrome P-450 CYP3ADiarrheaErbB ReceptorsMutationPolymorphism, Single NucleotideRetrospective StudiesSTAT3 Transcription FactorATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsAcrylamidesIndolesPyrimidines

Stichwörter der Autor:innen

ABCG2CYP3A5OsimertinibSTAT3adverse eventnon-small cell lung cancerpolymorphism

Substanzen

Aniline CompoundsAntineoplastic AgentsCytochrome P-450 CYP3AErbB ReceptorsProtein Kinase InhibitorsSTAT3 Transcription FactorATP Binding Cassette Transporter, Subfamily G, Member 2ABCG2 protein, humanNeoplasm ProteinsCYP3A5 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
  • Department of Pharmacy, Kobe University Hospital, Kobe, Japan; yamakz@med.kobe-u.ac.jp.
  • Department of Pharmacy, Nara Prefecture General Medical Center, Nara, Japan.
  • Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Division of Respiratory Medicine, Nara Prefecture General Medical Center, Nara, Japan.

Zitieren

APA

Tanda, M., Yamamoto, K., Hori, T., Nishiguchi, H., Yagi, M., Shimizu, M., Konishi, T., Ozaki, T., Yoshioka, N., Tachihara, M., Ito, T., Ikushima, S., Omura, T., & Yano, I. (2023). Association of STAT3, CYP3A5 , and ABCG2 Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients. Anticancer Research. https://doi.org/10.21873/anticanres.16331

Vancouver

Tanda M, Yamamoto K, Hori T, Nishiguchi H, Yagi M, Shimizu M, et al. Association of STAT3, CYP3A5 , and ABCG2 Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients. Anticancer Research. 2023. doi:10.21873/anticanres.16331

BibTeX
@article{Tanda2023,
  author = {Tanda, Masaaki and Yamamoto, Kazuhiro and Hori, Tomoki and Nishiguchi, Hiroki and Yagi, Miki and Shimizu, Michiko and Konishi, Toru and Ozaki, Tomonori and Yoshioka, Natsue and Tachihara, Motoko and Ito, Takefumi and Ikushima, Shigeki and Omura, Tomohiro and Yano, Ikuko},
  title = {Association of STAT3, CYP3A5 , and ABCG2 Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16331}
}
Kostenlos starten →